T-cell therapy represents a groundbreaking advancement in the field of immuno-oncology. This innovative treatment involves ...

Understanding Sickle Cell Anemia and the Need for Early DiagnosisSickle cell anemia is a genetic blood disorder caused by a ...

The global glucose monitoring devices market was valued at USD 14.1 billion in 2023 and is expected to grow to USD 15.67 ...

Reef Group (“Reef”), the leading property development and investment specialist, and BlackRock Real Estate, have completed ...

The chronic kidney disease drug development landscape is evolving at an unprecedented pace, driven by breakthrough approvals, billion-dollar mergers and acquisitions, and increasing regulatory support ...

Cellev8 Continues to breakthrough, enhance and improve the lives of athletes globally WELLINGTON, FL / ACCESS Newswire / February 11, 2025 / Innovative Wellness Company Teams Up with Hall of Famer to ...

Product Launch Leverages IGC's State-Of-The-Art Manufacturing Facility To Support Revenue-Generating Brand for Immunity & Energy - POTOMAC, MD / ACCESS Newswire / February 11, 2025 / IGC Pharma, Inc.

Aston Institute for Membrane Excellence (AIME) has been awarded £6.1m in funding from the UK Government Department of Science, Industry and Technology (DSIT), with a further £7.1m in co-funding from ...

Ellipses Pharma Limited (“Ellipses”), a global drug development company focused on accelerating the development of cancer treatments through an innovative drug development model, announced today it is ...

ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence immune enhancers to minimize the impact of viral respiratory infections, announces today it has received a ...

PALO ALTO, CALIFORNIA / ACCESS Newswire / February 11, 2025 / Bioz, Inc., an AI-powered citation management company at the forefront of scientific discovery, is excited to highlight the continued ...

Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, today announced the appointment of Dr Michael Murray as Chair of ...